Monday| September 23rd | 2 PM PST |

Dr. Frederick K. Johnson Founder & CEO of Digital Therapeutix discusses antimicrobial resistance and how Digital Therapeutix addresses this issue.

Special Guest: Dr. Frederick K. Johnson – International Strategic Advisor, Professor, Author, MES Dx Thought Leader, and Founder/CEO of Digital Therapeutix, Inc.

Points covered 

• The persistent danger of antimicrobial resistance in the United States
• What does Digital Therapeutix Inc. provide
• Target audience

Biography

Dr. Frederick K. Johnson is an esteemed international strategic advisor, professor, author, and MES Dx thought leader with over 20 years of experience in manufacturing information systems. His global network spans Europe, Asia, South Africa, and the US, enabling him to lead transformative IT initiatives and optimize Manufacturing Execution Systems. As a lifelong learner, he actively engages with diverse communities, prioritizing the collective good and committing to continuous personal and intellectual growth.

As the founder of Digital Therapeutix, Inc. (DTPx), Dr. Johnson is revolutionizing the fight against bacterial infections through an AI-powered cloud platform focused on bacteriophage therapy. By connecting patients, doctors, researchers, veterinarians, and farmers, DTPx offers innovative alternatives to antibiotics, featuring an accessible phage library and essential information to simplify advanced treatments across various fields. Through these efforts, Dr. Johnson blends technology and compassion to drive positive change.

Social Media:

www.linkedin.com/in/frederickkjohnson

Brought to you by the J.C. Cooley Foundation, "Equipping the Youth of Today for the Challenges of Tomorrow."

#ItsYourLife #Talkshow #Podcast #Radio # Digital Therapeutix